NewsBenzinga로스 캐피털, 노틸러스 바이오테크놀로지 투자의견 ‘매수’로 신규 개시···목표주가 3.5달러 제시 로스 캐피털, 노틸러스 바이오테크놀로지 투자의견 ‘매수’로 신규 개시···목표주가 3.5달러 제시 Benzinga 2026.09.29 09:31 (GMT+0) Open on Benzinga Other news Cybersecurity AI startup Corma reaches $1B valuation in about 3 months Here’s How Much You Would Have Made Owning Advanced Micro Devices Stock In The Last 15 Years Musk Says Owner Robotaxi Trials May Start in December Grupo Supervielle Q3 EPS $0.05 Misses $0.18 Estimate, Sales $149.304M Miss $252.530M Estimate Brad Gerstner Bets $5 Billion on Anthropic IPO: 'Cornerstone Compounder for a Long Time' NVIDIA Targets Desktop HPC With Four-Spark Developer Kit